The WACC of Hemogenyx Pharmaceuticals PLC (HEMO.L) is 11.5%.
| Range | Selected | |
| Cost of equity | 10.30% - 15.40% | 12.85% |
| Tax rate | 19.00% - 19.00% | 19.00% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 9.4% - 13.6% | 11.5% |
| Category | Low | High |
| Long-term bond rate | 4.0% | 4.5% |
| Equity market risk premium | 6.0% | 7.0% |
| Adjusted beta | 1.06 | 1.49 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 10.30% | 15.40% |
| Tax rate | 19.00% | 19.00% |
| Debt/Equity ratio | 0.18 | 0.18 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 9.4% | 13.6% |
| Selected WACC | 11.5% | |